Skip to menu Skip to content Skip to footer

2009

Conference Publication

Connexin expression patterns in the epidermal tumour microenvironment of melanoma are valuable biomarkers for diagnosis and prognosis

Haass, N. K., Ripperger, D., Wladykowski, E., Dawson, P., Gimotty, P. A., Reich, C., Fischer, F., Schmage, P., Moll, I. and Brandner, J. M. (2009). Connexin expression patterns in the epidermal tumour microenvironment of melanoma are valuable biomarkers for diagnosis and prognosis. 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research, Sydney Australia, May 21-22, 2008. NATURE PUBLISHING GROUP.

Connexin expression patterns in the epidermal tumour microenvironment of melanoma are valuable biomarkers for diagnosis and prognosis

2009

Conference Publication

Tight junction proteine in merkel cell carcinoma

Fuchs, F., Moll, I, Haass, N. K., Houdek, P., Wladykowski, E. and Brandner, J. M. (2009). Tight junction proteine in merkel cell carcinoma. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Tight junction proteine in merkel cell carcinoma

2009

Conference Publication

Novel small molecule kinase inhibitors with potent and specific anti-melanoma activity

Haass, N. K., Smalley, K. S., Lee, J. T., Weninger, W. and Herlyn, M. (2009). Novel small molecule kinase inhibitors with potent and specific anti-melanoma activity. 69th Annual Meeting of the Society-of-Investigative-Dermatology, Montreal Canada, May 06-09, 2009. NATURE PUBLISHING GROUP.

Novel small molecule kinase inhibitors with potent and specific anti-melanoma activity

2009

Conference Publication

Usability of Connexin 26, 30 and 43 as markers for diagnosis and prognosis of malignant melanoma

Haass, N. K., Ripperger, D., Wladykowski, E., Fischer, F., Schmage, P., Moll, I. and Brandner, J. M. (2009). Usability of Connexin 26, 30 and 43 as markers for diagnosis and prognosis of malignant melanoma. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL.

Usability of Connexin 26, 30 and 43 as markers for diagnosis and prognosis of malignant melanoma

2009

Conference Publication

ZO-1 in malignant melanoma and adjacent epidermis

Bohner, C., Haass, N. K., Ripperger, D., Wladykowski, E., Moll, I. and Brandner, J. (2009). ZO-1 in malignant melanoma and adjacent epidermis. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL.

ZO-1 in malignant melanoma and adjacent epidermis

2009

Conference Publication

Targeted therapy of melanoma: Novel kinase inhibitors with potent and specific anti-melanoma activity

Haass, N. K., Smalley, K. S., Lee, J. T. and Herlyn, M. (2009). Targeted therapy of melanoma: Novel kinase inhibitors with potent and specific anti-melanoma activity. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL.

Targeted therapy of melanoma: Novel kinase inhibitors with potent and specific anti-melanoma activity

2008

Conference Publication

COMP 374-Potent inhibitors of mutant-B-Raf and Fms kinases designed using a scaffold-based drug discovery approach

Artis, Dean R., Tsai, James, Bremer, Ryan, Zhang, Jiazhong, Cho, Hanna, Mamo, Shumeye, Spevak, Wayne, Gillette, Samuel, Kong, Jun, Fong, Daniel, Zhu, Yong-Liang, Wang, Weiru, Nespi, M., Marimuthu, Adhirai, Lam, Billy, Shi, Shenghua, Burton, Betsy, Guan, Yinghui, Liu, Jennifer, Cheung, Ivana, Rice, Julie, Wong, Bernice, Nguyen, Hoa, Suzuki, Yoshihisa, Luu, Catherine, Settachatgul, Calvin, Shellooe, Rafe, Cantwell, John, Haass, Nikolas K. ... Bollag, Gideon (2008). COMP 374-Potent inhibitors of mutant-B-Raf and Fms kinases designed using a scaffold-based drug discovery approach. 236th National Meeting of the American-Chemical-Society, Philadelphia Pa, Aug 17-21, 2008. AMER CHEMICAL SOC.

COMP 374-Potent inhibitors of mutant-B-Raf and Fms kinases designed using a scaffold-based drug discovery approach

2008

Conference Publication

Vertical and horizontal expression of Cx26 in epidermis adjacent to malignant melanoma correlates to tumor depth

Ripperger, D., Haass, N. K., Wladykowski, E., Fischer, F., Schmage, P., Moll, I. and Brandner, I. M. (2008). Vertical and horizontal expression of Cx26 in epidermis adjacent to malignant melanoma correlates to tumor depth. International Investigative Dermatology Meeting, Kyoto Japan, May 14-17, 2008. NATURE PUBLISHING GROUP.

Vertical and horizontal expression of Cx26 in epidermis adjacent to malignant melanoma correlates to tumor depth

2008

Conference Publication

Tumour depth influences vertical and horizontal expression of Cx26 in epidermis adjacent to malignant melanoma

Ripperger, D., Wladykowski, E., Haass, N. K., Fischer, F., Moll, I. and Brandner, J. M. (2008). Tumour depth influences vertical and horizontal expression of Cx26 in epidermis adjacent to malignant melanoma. 35th Annual Meeting of the Arbeitsgemeinschaft-Dermatolog-Forschung, Eriangen Germany, Feb 28-Mar 01, 2008. BLACKWELL PUBLISHING.

Tumour depth influences vertical and horizontal expression of Cx26 in epidermis adjacent to malignant melanoma

2007

Conference Publication

The novel MEK1/2 inhibitor AZD6244 (ARRY-142886) inhibits the growth of melanomas harboring the BRAF V600E mutation in vitro and in vivo

Haass, N. K., Smalley, K. S., Sproesser, K., Contractor, R. and Herlyn, M. (2007). The novel MEK1/2 inhibitor AZD6244 (ARRY-142886) inhibits the growth of melanomas harboring the BRAF V600E mutation in vitro and in vivo. 68th Annual Meeting of the Society-for-Investigative-Dermatology, Los Angeles Ca, May 09-12, 2007. NATURE PUBLISHING GROUP.

The novel MEK1/2 inhibitor AZD6244 (ARRY-142886) inhibits the growth of melanomas harboring the BRAF V600E mutation in vitro and in vivo

2006

Conference Publication

The microenvironment is the key determinant of melanoma drug resistance

Haass, N. K., Smalley, K. S. and Herlyn, M. (2006). The microenvironment is the key determinant of melanoma drug resistance. 67th Annual Meeting of the Society-for-Investigative-Dermatology, Philadelphia Pa, May 03-06, 2006. NATURE PUBLISHING GROUP.

The microenvironment is the key determinant of melanoma drug resistance

2005

Conference Publication

Differential gap junctional intercellular communication between melanoma cells and cells in their microenvironment

Haass, N, Brandner, J, Brafford, P, Wladykowski, E, Kazianis, S, Moll, I and Herlyn, M (2005). Differential gap junctional intercellular communication between melanoma cells and cells in their microenvironment. 35th Annual Meeting of the European-Society-for-Dermatological-Research, Tubingen Germany, Sep 22-24, 2005. BLACKWELL PUBLISHING.

Differential gap junctional intercellular communication between melanoma cells and cells in their microenvironment

2004

Conference Publication

Connexins 26 and 43 are differentially induced in skin tumors and the adjacent epidermis

Haass, NK, Wladykowski, E, Kief, S, Moll, I and Brandner, JM (2004). Connexins 26 and 43 are differentially induced in skin tumors and the adjacent epidermis. 34th Annual Meeting of the European-Society-for-Dermatological-Research, Vienna Austria, Sep 09-11, 2004. BLACKWELL PUBLISHING INC.

Connexins 26 and 43 are differentially induced in skin tumors and the adjacent epidermis

2004

Conference Publication

Connexins are differentially expressed in melanoma and adjacent epidermis

Haass, NK, Brandner, JM, Brafford, PA, Wladykowski, E, Kazianis, S, Smalley, KS, Moll, I and Herlyn, M (2004). Connexins are differentially expressed in melanoma and adjacent epidermis. 65th Annual Meeting of the Society-for-Investigative-Dermatology, Providence Ri, Apr 28-May 01, 2004. BLACKWELL PUBLISHING INC.

Connexins are differentially expressed in melanoma and adjacent epidermis

2002

Conference Publication

Induction of connexins Cx30 and Cx26 in epidermis adjacent to malignant melanoma but not to melanocytic nevi

Haass, NK, Brandner, JM, Wladykowski, E, von den Driesch, P, Kief, S, Houdek, P and Moll, I (2002). Induction of connexins Cx30 and Cx26 in epidermis adjacent to malignant melanoma but not to melanocytic nevi. BLACKWELL PUBLISHING INC.

Induction of connexins Cx30 and Cx26 in epidermis adjacent to malignant melanoma but not to melanocytic nevi

2002

Conference Publication

Treosulfan and gemcitabine in metastatic uveal melanoma: First multicenter experience

Pfohler, C, Ugurel, S, Cree, IA, Plowman, N, Kuwert, C, Neuber, K, Haass, N, Tilgen, W and Reinhold, U (2002). Treosulfan and gemcitabine in metastatic uveal melanoma: First multicenter experience. BLACKWELL PUBLISHING INC.

Treosulfan and gemcitabine in metastatic uveal melanoma: First multicenter experience

2002

Conference Publication

Do tight junctions play a role in the barrier function of the skin?

Brandner, JM, Proksch, E, Von den Driesch, P, Kief, S, Wladykowski, E, Haass, NK and Moll, I (2002). Do tight junctions play a role in the barrier function of the skin?. BLACKWELL PUBLISHING INC.

Do tight junctions play a role in the barrier function of the skin?

2002

Conference Publication

Changes in expression patterns of tight junction proteins in malignant melanoma and adjacent epidermis compared to melanocytic nevi

Haass, NK, Brandner, JM, von den Driesch, P, Wladykowski, E, Kief, S, Houdek, P and Moll, I (2002). Changes in expression patterns of tight junction proteins in malignant melanoma and adjacent epidermis compared to melanocytic nevi. BLACKWELL PUBLISHING INC.

Changes in expression patterns of tight junction proteins in malignant melanoma and adjacent epidermis compared to melanocytic nevi

2001

Conference Publication

Expression and localisation of various tight-junction-proteins in the human epidermis and various diseases

Brandner, J, Haass, NK, Kief, S, Wladykowski, E, Houdek, P and Moll, I (2001). Expression and localisation of various tight-junction-proteins in the human epidermis and various diseases. BLACKWELL SCIENCE INC.

Expression and localisation of various tight-junction-proteins in the human epidermis and various diseases

2001

Conference Publication

Induction of gap junction proteins in epithelial skin tumours and adjacent epidermis

Haass, NK, Brandner, JM, von den Driesch, P, Kief, S, Wladykowski, E, Houdek, P and Moll, I (2001). Induction of gap junction proteins in epithelial skin tumours and adjacent epidermis. BLACKWELL SCIENCE INC.

Induction of gap junction proteins in epithelial skin tumours and adjacent epidermis